| Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 J Arizti-Sanz, CA Freije, AC Stanton, BA Petros, CK Boehm, S Siddiqui, ... Nature communications 11 (1), 5921, 2020 | 389 | 2020 |
| Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species M Tabebordbar, KA Lagerborg, A Stanton, EM King, S Ye, L Tellez, ... Cell 184 (19), 4919-4938. e22, 2021 | 360 | 2021 |
| Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2 J Arizti-Sanz, CA Freije, AC Stanton, CK Boehm, BA Petros, S Siddiqui, ... BioRxiv, 2020 | 45 | 2020 |
| Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS AC Stanton, KA Lagerborg, L Tellez, A Krunnfusz, EM King, S Ye, ... Med 4 (1), 31-50. e8, 2023 | 44 | 2023 |
| Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nat. Commun. 11, 5921 J Arizti-Sanz, CA Freije, AC Stanton, BA Petros, CK Boehm, S Siddiqui, ... | 7 | 2020 |
| Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2. bioRxiv. 2020 J Arizti-Sanz, CA Freije, AC Stanton, CK Boehm, BA Petros, S Siddiqui, ... Preprint, 0 | 5 | |
| Pan-viral ORFs discovery using massively parallel ribosome profiling S Weingarten-Gabbay, MR Bauer, AC Stanton, S Klaeger, EK Verzani, ... bioRxiv, 2023.09. 26.559641, 2023 | 3 | 2023 |
| Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2, Nat. Commun. 11 (2020) 5921 J Arizti-Sanz, CA Freije, AC Stanton, BA Petros, CK Boehm, S Siddiqui, ... | 3 | |
| ENGINEERED MUSCLE TARGETING COMPOSITIONS P Sabeti, M Tabebordbar, S Ye, K Lagerborg, A Stanton, A Wagers US Patent App. 18/915,615, 2025 | | 2025 |
| Engineered central nervous system compositions P Sabeti, M Tabebordbar, S Ye, A Stanton, K Lagerborg US Patent App. 18/690,307, 2025 | | 2025 |
| Massively Parallel Approaches to Functional Characterization of Natural and Engineered Viruses AC Stanton | | 2024 |
| Crispr effector system based diagnostics for virus detection P Sabeti, C Myhrvold, JA Sanz, A Stanton, B Petros US Patent App. 18/023,538, 2024 | | 2024 |
| Engineered muscle targeting compositions P Sabeti, M Tabebordbar, S Ye, K Lagerborg, A Stanton, A Wagers US Patent App. 17/614,327, 2023 | | 2023 |
| I. 11 Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species S Tabebordbar, K Lagerborg, S Ye, A Stanton, E King, L Tellez, ... Neuromuscular Disorders 32, S96, 2022 | | 2022 |
| Engineered muscle targeting compositions P Sabeti, M Tabebordbar, S Ye, K Lagerborg, A Stanton, A Wagers US Patent App. 17/707,944, 2022 | | 2022 |
| Systemic Administration of Novel Engineered AAV Capsids Facilitates Enhanced Transgene Expression in the Macaque Central Nervous System AC Stanton, KA Lagerborg, A Krunnfusz, L Tellez, EM King, S Ye, ... MOLECULAR THERAPY 30 (4), 207-208, 2022 | | 2022 |
